Myocarditis is a common cardiovascular manifestation seen in patients diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, because of the similarity of presentation with other cardiopulmonary pathologies, identification of coronavirus disease 2019 (COVID-19) related myocarditis can be challenging. Transthoracic echocardiography is a key component in initial diagnosis. COVID-19 related myocarditis is increasingly identified as an underlying problem in COVID-19 patients with low ejection fraction. Early recognition is critical with a low threshold for screening echocardiogram. Utilization of cardiac MRI (CMRI) can be helpful in recognition of early manifestations of COVID-19 myocarditis, with the added benefit of avoidance of invasive testing such as endomyocardial biopsy (EMB). Once diagnosis is established, disease-specific treatment can lead to rapid recovery of ventricular systolic function. We present a case series including two similar cases of COVID-19 myocarditis in which we utilized echocardiography as an early diagnostic tool and prompt treatment led to better prognosis.
【저자키워드】 COVID-19, myocarditis, Cardiac MRI, covid-induced myocarditis, echo cardiogram, 【초록키워드】 Treatment, coronavirus disease, SARS-CoV-2, Prognosis, Infection, Cardiopulmonary, diagnostic, Diagnosis, MRI, Patient, utilization, threshold, Pathologies, Critical, Coronavirus-2, similarity, COVID-19 patient, manifestation, transthoracic echocardiography, acute respiratory syndrome, Echocardiogram, Ejection fraction, avoidance, benefit, invasive, initial, diagnosed, case sery, added, increasingly, EMB, ventricular, 【제목키워드】 rationale,